Royal Bank Of Canada Meridian Bioscience Inc Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $33,797 - $36,228	1,085 Added 6.86%	16,910 $561,000
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $826,605 - $897,496	-26,751 Reduced 62.83%	15,825 $499,000
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $569,525 - $759,926	23,980 Added 128.95%	42,576 $1.3 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $69,535 - $93,805	-3,482 Reduced 15.77%	18,596 $482,000
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $88,434 - $109,454	5,065 Added 29.77%	22,078 $451,000
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $15,424 - $20,002	889 Added 5.51%	17,013 $327,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $290,393 - $456,631	16,124 New	16,124 $358,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.